Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Image

[Articles] Perioperative chemotherapy and stereotactic body radiotherapy versus perioperative chemotherapy alone in patients with high-risk, localised pancreatic cancer (MASTERPLAN): an open-label, phase 2, multicentre, randomised trial of the Australasian Gastro-Intestinal Trials Group

Journal content Created on 23 Oct 2026 The Lancet Oncology

Published in

The Lancet Oncology, The Lancet (Reed Elsevier)

Content

There is no additional content. Please click on the source link to view more information.

Advertisement

Stats

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 70
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement